Fit for purpose high‐throughput absolute quantitation of chimeric aducanumab in mouse cortex and plasma

Emma H Doud, Kathryn A Haynes, Diogo Francisco Silva Santos, Amber L Mosley, Sara K Quinney, Stacey J Sukoff Rizzo, Paul R Territo · 2025

Read Fit for purpose high‐throughput absolute quantitation of chimeric aducanumab in mouse cortex and plasma by Emma H Doud, Kathryn A Haynes, Diogo Francisco Silva Santos, Amber L Mosley, Sara K Quinney, Stacey J Sukoff Rizzo, Paul R Territo (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11709830.txt.

Description

Seven authors build a fast mass spec count for a brain drug in mouse tissue in 2025. Glue-based tests fail on tight-bind drugs, with murk and bent curves. Their path picks drug-only bits, spikes in marked twin bits, and reads counts by mass steps.

The count stays straight across a huge span, with repeat spread of three to ten percent. A catch step with a bind protein cut the floor a hundred-fold. One plate of 96 samples runs in two to three days, and the flow is shared for like drug work.

Catalog record

CREATOREmma H Doud, Kathryn A Haynes, Diogo Francisco Silva Santos, Amber L Mosley, Sara K Quinney, Stacey J Sukoff Rizzo, Paul R Territo
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11709830

Browse the full library · About the Tower of Babel